tp53
Entity, reached from Hormuz.
- Evidence
- 59 documents · 17 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 31 Mar 2026, last seen 7 Oct 2026
- Measured
- 12% of mentions say something specific about it; the rest only name it
- As of
- 10 Oct 2026
Where this comes from
- Inside Precision Medicine · 2026-09-19 · Tumors Can Hide p53 Neoantigens from T Cells, Study Finds (opens the source in a new tab)
- crc-kras · 2026-09-09 · CAMOR and specific oncogene-driven lncRNAs mediate carcinogenic functions downstream of MYC, mutant KRAS, and mutant TP53 (opens the source in a new tab)
- Int J Mol Sci · 2026-09-09 · Artificial Intelligence-Based Prediction of Molecular Alterations in Colorectal Cancer Using Routine H&E Whole-Slide Images. (opens the source in a new tab)
- Mol Ther Oncol · 2026-08-26 · A p53R273H-selective bispecific T cell engager: Computational design and functional validation. (opens the source in a new tab)
- Front Med (Lausanne) · 2026-08-25 · Fulminant development of a giant pelvic metastasis from microsatellite-stable early-onset sigmoid colon cancer with KRAS and TP53 co-mutations: a case report. (opens the source in a new tab)
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with immunotherapy (30 documents)seen together
- co-mentioned with kras (19 documents)seen together
- co-mentioned with clinical trials (19 documents)seen together
- co-mentioned with china (17 documents)seen together
- co-mentioned with united states (17 documents)seen together
- co-mentioned with colorectal cancer (15 documents)seen together
- co-mentioned with ctdna (15 documents)seen together
- co-mentioned with lung cancer (14 documents)seen together
- co-mentioned with breast cancer (14 documents)seen together
- co-mentioned with pi3k (13 documents)seen together